Teams are getting leaner and flatter, while leaders at the top are overseeing more than ever before. Everyone, everywhere is ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

The WHO lowered its assessment from high to medium, based on several factors, including high population immunity and improved ...

Recent CDC data show that that wastewater SARS-CoV-2 detections are high and that LP.8.1 and related strains XFG and NB.1.8.1 ...

The World Health Organisation claims their roll-out prevented 14.4 million deaths worldwide in their first year, with some ...

Lilly claimed success in a head-to-head trial of oral GLP-1 drugs. Elsewhere, Novo planned a new weight loss trial and an ...

Shares of Moderna MRNA were up 4% yesterday after the company announced positive preliminary immunogenicity data from an ...

With confusion about eligibility for COVID-19 vaccines, Gov. Gretchen Whitmer is expected to sign an executive directive ...

Moderna, Inc. (NASDAQ:MRNA) shares are up nearly 5% on Tuesday after the company announced positive preliminary ...

A two-day meeting could prove an inflection point in HHS Secretary’s Kennedy’s efforts to overhaul U.S. vaccine policy, as ...

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in ...

Trump health officials plan to link coronavirus vaccines to the deaths of 25 children as they consider limiting which Americans should get the shots, according to four people familiar with the ...